Purpose: To determine whether combined modality Positron Emission Tomography and Computed Tomography (PET-CT) imaging can pre-operatively identify de-differentiated areas within well-differentiated liposarcomas/ atypical lipomatous neoplasms. Well-differentiated lipo-sarcomas show a reasonably homogeneous lesion with fat signal characteristics on MRI and are managed with surgical excision or regular observation. They can recur locally, but never metastasize. Up to 5% of well-differentiated liposarcomas will contain a de-differentiated component that is not apparent on MRI. When present, this de-differentiated component carries a much worse prognosis and requires more aggressive local management. Currently this is only identified after surgical resection. Pre-operative identification of a de-differentiated component within the lesion by PET-CT would allow for better treatment planning. However, PET-CT is an expensive investigation and has not been reported in this application before, although it has been used for imaging of soft tissue tumours.

Method: We have prospectively enrolled 40 subjects into this study. Eligible subjects presented with a > 8cm and deep well-differentiated liposarcoma in the extremities or retroperitoneum, which was confirmed by MRI. Subjects underwent a pre-operative PET-CT scan to look for areas of de-differentiation within the lesion. The PET-CT results were compared to the final pathological analysis of the surgical specimen. When necessary for diagnostic purposes, cytogenetic analysis was also completed.

Results: Thirty-one of the 40 subjects enrolled have had PET-CT scan and surgery. Seven subjects are waiting for PET-CT and surgery by December 2009. Two subjects were withdrawn from the study: one because the PET-CT scan could not be scheduled prior to surgery, and one because the subject ultimately declined surgery. Of the 31 lesions excised, 2 contained de-differentiated areas within the lesion. The PET-CT detected a small area of low to moderate FDG uptake (thigh lesion, max Standard Uptake Value (SUV) 3.6) for one of these patients; however no uptake on PET-CT was seen for the other (retroperitoneal lesion, max SUV 1.7).

Conclusion: PET-CT does not appear to reliably detect de-differentiated areas within well-differentiated lipo-sarcomas. Our data does not support the use of PET-CT for this purpose as it may be misleading and wasteful of resources.

Introduction Morbidity associated with wound complications may translate into disability and quality-of-life disadvantages for patients treated with radiotherapy (RT) for soft tissue sarcoma (STS) of the extremities. Functional outcome and health status of extremity STS patients randomized in a phase III trial comparing pre-operative versus post-operative RT is described.

Methods One hundred and ninety patients with extremity STS were randomized after stratification by tumor size dichotomized at 10 cm. Function and quality of life were measured by the Musculoskeletal Tumor Society Rating Scale (MSTS), the Toronto Extremity Salvage Score (TESS), and the Short Form-36 (SF-36) at randomization, six weeks, and three, six, 12, and 24 months after surgery. One hundred and eighty-five patients had function data.

Results Patients treated with post-operative RT had better function with higher MSTS (25.8 v 21.3, P < .01), TESS (69.8 v 60.6, P =.01), and SF-36 bodily pain (67.7 v 58.5, P =.03) scores at six weeks after surgery. There were no differences at later time points. Scores on the physical function, role-physical, and general health sub-scales of the SF-36 were significantly lower than Canadian normative data at all time points. After treatment arm was controlled for, MSTS change scores were predicted by a lower-extremity tumor, a large resection specimen, and motor nerve sacrifice; TESS change scores were predicted by lower-extremity tumor and prior incomplete excision. When wound complication was included in the model, patients with complications had lower MSTS and TESS scores in the first two years after treatment.

Conclusions The timing of RT has minimal impact on the function of STS patients in the first year after surgery. Tumor characteristics and wound complications have a detrimental effect on patient function.